Literature DB >> 18776913

Viral vectors: from virology to transgene expression.

D Bouard1, D Alazard-Dany, F-L Cosset.   

Abstract

In the late 1970s, it was predicted that gene therapy would be applied to humans within a decade. However, despite some success, gene therapy has still not become a routine practise in medicine. In this review, we will examine the problems, both experimental and clinical, associated with the use of viral material for transgenic insertion. We shall also discuss the development of viral vectors involving the most important vector types derived from retroviruses, adenoviruses, herpes simplex viruses and adeno-associated viruses.

Entities:  

Mesh:

Year:  2009        PMID: 18776913      PMCID: PMC2629647          DOI: 10.1038/bjp.2008.349

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  131 in total

Review 1.  Ebola virus glycoproteins: guidance devices for targeting gene therapy vectors.

Authors:  David A Sanders
Journal:  Expert Opin Biol Ther       Date:  2004-03       Impact factor: 4.388

2.  Cell-culture assays reveal the importance of retroviral vector design for insertional genotoxicity.

Authors:  Ute Modlich; Jens Bohne; Manfred Schmidt; Christof von Kalle; Sabine Knöss; Axel Schambach; Christopher Baum
Journal:  Blood       Date:  2006-07-06       Impact factor: 22.113

3.  High-titer packaging cells producing recombinant retroviruses resistant to human serum.

Authors:  F L Cosset; Y Takeuchi; J L Battini; R A Weiss; M K Collins
Journal:  J Virol       Date:  1995-12       Impact factor: 5.103

4.  Type C retrovirus inactivation by human complement is determined by both the viral genome and the producer cell.

Authors:  Y Takeuchi; F L Cosset; P J Lachmann; H Okada; R A Weiss; M K Collins
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

Review 5.  Precise hit: adeno-associated virus in gene targeting.

Authors:  Ana Vasileva; Rolf Jessberger
Journal:  Nat Rev Microbiol       Date:  2005-11       Impact factor: 60.633

6.  Lentiviral vectors pseudotyped with a modified RD114 envelope glycoprotein show increased stability in sera and augmented transduction of primary lymphocytes and CD34+ cells derived from human and nonhuman primates.

Authors:  Virginie Sandrin; Bertrand Boson; Patrick Salmon; Wilfried Gay; Didier Nègre; Roger Le Grand; Didier Trono; François-Loïc Cosset
Journal:  Blood       Date:  2002-08-01       Impact factor: 22.113

7.  Self-inactivating retroviral vectors designed for transfer of whole genes into mammalian cells.

Authors:  S F Yu; T von Rüden; P W Kantoff; C Garber; M Seiberg; U Rüther; W F Anderson; E F Wagner; E Gilboa
Journal:  Proc Natl Acad Sci U S A       Date:  1986-05       Impact factor: 11.205

8.  Hot spots of retroviral integration in human CD34+ hematopoietic cells.

Authors:  Claudia Cattoglio; Giulia Facchini; Daniela Sartori; Antonella Antonelli; Annarita Miccio; Barbara Cassani; Manfred Schmidt; Christof von Kalle; Steve Howe; Adrian J Thrasher; Alessandro Aiuti; Giuliana Ferrari; Alessandra Recchia; Fulvio Mavilio
Journal:  Blood       Date:  2007-05-16       Impact factor: 22.113

9.  Hematopoietic stem cell gene transfer in a tumor-prone mouse model uncovers low genotoxicity of lentiviral vector integration.

Authors:  Eugenio Montini; Daniela Cesana; Manfred Schmidt; Francesca Sanvito; Maurilio Ponzoni; Cynthia Bartholomae; Lucia Sergi Sergi; Fabrizio Benedicenti; Alessandro Ambrosi; Clelia Di Serio; Claudio Doglioni; Christof von Kalle; Luigi Naldini
Journal:  Nat Biotechnol       Date:  2006-05-28       Impact factor: 54.908

Review 10.  A look to future directions in gene therapy research for monogenic diseases.

Authors:  Matthew H Porteus; Jon P Connelly; Shondra M Pruett
Journal:  PLoS Genet       Date:  2006-09-29       Impact factor: 5.917

View more
  86 in total

1.  Intracellular gene transfer in rats by tail vein injection of plasmid DNA.

Authors:  Tian Zhou; Kenya Kamimura; Guisheng Zhang; Dexi Liu
Journal:  AAPS J       Date:  2010-09-22       Impact factor: 4.009

2.  Influence of plasmid concentration on DNA electrotransfer in vitro using high-voltage and low-voltage pulses.

Authors:  Karolina Cepurniene; Paulius Ruzgys; Rimantas Treinys; Ingrida Satkauskiene; Saulius Satkauskas
Journal:  J Membr Biol       Date:  2010-07-10       Impact factor: 1.843

3.  Delivery of magic bullets: on the still rocky road to gene therapy.

Authors:  K Takeda
Journal:  Br J Pharmacol       Date:  2009-05       Impact factor: 8.739

4.  Effect of fetal bovine serum on foamy and lentiviral vector production.

Authors:  John M Powers; Grant D Trobridge
Journal:  Hum Gene Ther Methods       Date:  2013-08-28       Impact factor: 2.396

5.  5-HT1B autoreceptors differentially modulate the expression of conditioned fear in a circuit-specific manner.

Authors:  Y Liu; M A Kelly; T J Sexton; J F Neumaier
Journal:  Neuroscience       Date:  2015-04-20       Impact factor: 3.590

Review 6.  Challenges of gene delivery to the central nervous system and the growing use of biomaterial vectors.

Authors:  Devan L Puhl; Anthony R D'Amato; Ryan J Gilbert
Journal:  Brain Res Bull       Date:  2019-06-05       Impact factor: 4.077

Review 7.  Therapeutic potential of combined viral transduction and CRISPR/Cas9 gene editing in treating neurodegenerative diseases.

Authors:  Joshua Kuruvilla; Andrew Octavian Sasmita; Anna Pick Kiong Ling
Journal:  Neurol Sci       Date:  2018-08-03       Impact factor: 3.307

8.  Lentiviral Vector-mediated Gene Therapy of Hepatocytes Ex Vivo for Autologous Transplantation in Swine.

Authors:  Robert A Kaiser; Shennen A Mao; Jaime Glorioso; Bruce Amiot; Clara T Nicolas; Kari L Allen; Zeji Du; Caitlin J VanLith; Raymond D Hickey; Scott L Nyberg; Joseph B Lillegard
Journal:  J Vis Exp       Date:  2018-11-04       Impact factor: 1.355

9.  Non-viral gene-activated matrices: next generation constructs for bone repair.

Authors:  Erica G Tierney; Garry P Duffy; Sally-Ann Cryan; Caroline M Curtin; Fergal J O'Brien
Journal:  Organogenesis       Date:  2013-01-01       Impact factor: 2.500

10.  Using viral vectors as gene transfer tools (Cell Biology and Toxicology Special Issue: ETCS-UK 1 day meeting on genetic manipulation of cells).

Authors:  Joanna L Howarth; Youn Bok Lee; James B Uney
Journal:  Cell Biol Toxicol       Date:  2009-10-15       Impact factor: 6.691

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.